Clinically, diagnostic methods for liver cancer include imaging examinations (dynamic contrast-enhanced magnetic resonance imaging (MRI), dynamic contrast-enhanced computed tomography (CT), and selective hepatic arteriography), the alpha-fetoprotein (AFP) indicators in blood-drawn results, and liver lesion tissue biopsy. This evidence concerns the gene AFP and liver cancer.